Sauna and Heat Therapy Lower Blood Pressure—Modestly

Regular sauna bathing and other forms of passive heat therapy can lower blood pressure by a modest, measurable amount. The best pooled estimate is about 4 mmHg for both systolic and diastolic pressure after repeated sessions. That is useful, especially for people with mildly elevated pressure, but it does not make heat an exercise substitute or a proven cure for vascular aging.

This is a meaningful upgrade from the older sauna story. Finnish cohort studies linked frequent sauna use with lower cardiovascular mortality, including a 2023 study of middle-aged and older Finnish men. Those associations were worth investigating, but people who use saunas often may also differ in income, fitness, diet, alcohol use, and healthcare access. Randomized trials cannot solve every problem, but they do a better job testing whether repeated heat exposure itself changes a physiological outcome.

The measurable benefit is blood pressure

A 2022 systematic review and meta-analysis by Pizzey et al. pooled 15 studies of repeated heat therapy, including sauna bathing and hot-water-based protocols. Participants typically completed 10 to 36 sessions lasting 30 to 90 minutes. Across 10 studies, systolic blood pressure fell by 3.94 mmHg versus control (95% CI, −7.22 to −0.67; P=0.02). Across nine studies, diastolic pressure fell by 3.88 mmHg (95% CI, −6.13 to −1.63; P=0.0007).

Four studies also reported mean arterial pressure, which fell by 5.86 mmHg (95% CI, −8.63 to −3.10; P<0.0001). The review rated certainty as moderate for systolic and diastolic pressure, but low for mean arterial pressure because only four studies contributed to that estimate.

A later 2025 meta-analysis by Hamaya et al. examined 20 randomized controlled trials through November 2024. It used an RCT-only design and treated the roughly 4 mmHg systolic and diastolic reductions from the earlier review as the field’s prior benchmark. Its broader scope included glucose, lipids, inflammation, arterial stiffness, and heart-rate variability, but the blood-pressure result remains the part of the literature with the most credible practical signal.

Four millimeters of mercury will not replace antihypertensive medication when medication is indicated. It may, however, matter for someone near a diagnostic threshold, such as systolic pressure of 130 to 139 mmHg, and it can complement established treatment. Blood pressure is also a direct clinical risk factor, unlike many wellness metrics marketed with a suspicious amount of confidence and very little follow-up.

What the trials do not establish

The same 2022 review found no statistically significant change in resting heart rate after chronic heat exposure: −1.25 beats per minute (95% CI, −3.20 to 0.70; P=0.21; 10 studies). The confidence interval crosses zero, so the result does not support a reliable chronic heart-rate effect.

That finding fits a 2023 systematic review of autonomic responses to passive heating, which found no definitive evidence that heating consistently remodels cardiovascular autonomic regulation. Aerobic training commonly changes resting heart rate through cardiac and autonomic adaptation. Passive heat may raise heart rate during a session, but an acute response is not proof of a training effect.

Claims about endothelial function need even more restraint. Pizzey and colleagues reported a 1.95 percentage-point improvement in flow-mediated dilation, or FMD (95% CI, 0.14 to 3.76; P=0.03; five studies). FMD is a surrogate measure of blood-vessel function, not a cardiovascular event outcome. More importantly, that pooled analysis included randomized and non-randomized studies, had substantial heterogeneity, and received a low-certainty GRADE rating.

Hamaya et al. restricted their analysis to randomized trials and described the earlier FMD evidence as not definitive. The difference matters: a pooled number can look reassuring while still depend on weaker study designs or a few small studies.

A coronary-disease trial puts the FMD claim in perspective

Debray et al. conducted an eight-week randomized Finnish-sauna trial in adults with established coronary artery disease. The trial found no significant improvement in FMD or pulse-wave velocity, a measure of arterial stiffness. This was not a study of healthy people trying to optimize an already normal cardiovascular profile; it tested a clinically important population with existing disease.

The null result does not prove that people with coronary artery disease can never benefit from sauna use. It does mean that chronic heat exposure has not reliably demonstrated vascular remodeling in that population. Medication use, existing endothelial dysfunction, protocol differences, and limited trial size could all affect the result. The available evidence cannot identify which explanation dominates.

It also explains why a modest blood-pressure benefit should not be inflated into a claim that sauna "reverses" arterial disease. A reduction in pressure and a sustained improvement in FMD are different endpoints. The trials have better support for the first.

Heat does not add metabolic benefits to exercise

Heat has often been sold as exercise in a wooden room. The evidence does not support that comparison. In a 2025 randomized trial by Steward et al., middle-aged inactive adults performed exercise with or without post-exercise hot-water immersion three times weekly for eight to 10 weeks. Adding immersion improved hemodynamic and vascular outcomes beyond exercise alone, but it did not further improve cardiorespiratory fitness, glucose, lipids, or inflammatory markers.

That result matches the broader uncertainty in Hamaya and colleagues’ RCT review. The review assessed fasting glucose, insulin, HbA1c, cholesterol fractions, triglycerides, CRP, IL-6, TNF-α, arterial stiffness, and heart-rate variability. It did not establish a chronic benefit across that cardiometabolic panel. Some outcomes may require different protocols or populations; others may simply be unaffected by passive heat. Either way, the current trials do not justify metabolic-multiplier claims.

Modality probably matters less than sustained exposure for blood pressure, although the evidence is still incomplete. A 2025 experimental comparison of steam sand bathing, hot-water immersion, and sauna found comparable acute blood-pressure reductions, with less discomfort and respiratory strain during the sand-bath condition. Acute equivalence does not prove that all formats produce identical chronic adaptations. Likewise, a 2025 study in 20 healthy young adults compared continuous 60-minute heating with three 20-minute heating blocks separated by cooling periods; the protocols produced different thermal responses. Traditional sauna use is often intermittent, while many trials use continuous exposure.

How to use the evidence

The trials included at least about 10 sessions, generally 30 to 90 minutes each. That gives a practical lower boundary for the protocols that produced the pooled blood-pressure estimates, not a proven minimum effective dose. No published result here shows that a brief, occasional sauna visit creates the same chronic effect.

• Use sauna, hot-water immersion, or another tolerable heat format as an adjunct for blood-pressure management, not as a replacement for exercise, medication, or medical care.
• Expect a modest average effect. Individual responses can differ because the trials varied in temperature, session duration, total sessions, modality, and participant health.
• Do not choose heat therapy chiefly to improve cholesterol, glucose control, inflammation, resting heart rate, or fitness. The RCT evidence does not support those outcomes.
• Talk with a clinician before starting regular heat exposure if you have established cardiovascular disease or take vasoactive or antihypertensive medication. The coronary-disease sauna trial did not show improved FMD or pulse-wave velocity.

Regular passive heat therapy has credible evidence for a small chronic reduction in blood pressure. It has not yet earned broader claims about metabolic health, autonomic remodeling, or reversal of vascular disease.

The limitations are real. Participants cannot be blinded to sitting in a sauna or soaking in hot water. Individual trials were often small, generally with fewer than 50 participants per arm. The blood-pressure protocols ranged from 30 to 90 minutes per session and roughly two to 15 weeks, and the pooled systolic estimate has a wide confidence interval. Hamaya et al. also found that individual small studies could influence pooled significance in sensitivity analyses. Regular heat exposure looks like a reasonable cardiovascular add-on for people who enjoy it and can use it safely. The science supports that modest claim; it asks us to leave the superhero origin story in the locker room.